A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 22,041 shares of AMGN stock, worth $6.17 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
22,041
Previous 21,785 1.18%
Holding current value
$6.17 Million
Previous $6.81 Million 4.33%
% of portfolio
0.27%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$309.38 - $337.38 $79,201 - $86,369
256 Added 1.18%
22,041 $7.1 Million
Q2 2024

Jul 11, 2024

BUY
$262.75 - $319.31 $23,384 - $28,418
89 Added 0.41%
21,785 $6.81 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $1.33 Million - $1.6 Million
4,931 Added 29.41%
21,696 $6.17 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $941,998 - $1.06 Million
-3,684 Reduced 18.02%
16,765 $4.83 Million
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $21,427 - $26,603
-98 Reduced 0.48%
20,449 $5.5 Million
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $30,640 - $36,231
143 Added 0.7%
20,547 $4.56 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $171,826 - $209,427
761 Added 3.87%
20,404 $4.93 Million
Q4 2022

Feb 03, 2023

SELL
$229.03 - $291.01 $91,612 - $116,404
-400 Reduced 2.0%
19,643 $5.16 Million
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $465,305 - $524,779
2,073 Added 11.54%
20,043 $4.52 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $9,459 - $10,526
-41 Reduced 0.23%
17,970 $4.37 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $2.53 Million - $2.8 Million
-11,527 Reduced 39.02%
18,011 $4.36 Million
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $404,720 - $463,166
-2,035 Reduced 6.45%
29,538 $6.65 Million
Q3 2021

Nov 01, 2021

BUY
$212.27 - $248.7 $6.7 Million - $7.85 Million
31,573 New
31,573 $6.71 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.